Ivana Magovcevic-Liebisch is the founder of Vigil Neuroscience. Vigil Neuroscience has raised $350M in total funding. Latest round: IPO.
Ivana Magovcevic-Liebisch is the President and CEO of Draig Therapeutics, a clinical-stage company focused on treating neuropsychiatric diseases. She previously founded, built, and led Vigil Neuroscience until its acquisition by Sanofi in August 2025. Under her leadership, Vigil evolved from inception to a clinical-stage organization within 18 months, raising over $350 million and advancing lead candidates into clinical development.
Full founder directory · Investor directory · Company funding database · Fundraising library